2,842 reports of this reaction
3.1% of all FENOFIBRATE reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for FENOFIBRATE, manufactured by AbbVie Inc.. There are 2,842 FDA adverse event reports linking FENOFIBRATE to FATIGUE. This represents approximately 3.1% of all 92,182 adverse event reports for this drug.
Patients taking FENOFIBRATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among FENOFIBRATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for FENOFIBRATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,842 FDA reports for FENOFIBRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.1% of all adverse event reports for FENOFIBRATE, making it one of the most commonly reported side effect.
If you experience fatigue while taking FENOFIBRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.